Glucosylceramide administration as a vaccination strategy in mouse models of cryptococcosis

V Mor, AM Farnoud, A Singh, A Rella, H Tanno, K Ishii… - PloS one, 2016 - journals.plos.org
Cryptococcus neoformans is an opportunistic fungal pathogen and the causative agent of
the disease cryptococcosis. Cryptococcosis is initiated as a pulmonary infection and in …

Monoclonal Antibody to Fungal Glucosylceramide Protects Mice against Lethal Cryptococcus neoformans Infection

ML Rodrigues, L Shi, E Barreto-Bergter… - Clinical and Vaccine …, 2007 - Am Soc Microbiol
Glucosylceramides (GlcCer) are involved in the regulation of Cryptococcus neoformans
virulence. In the present study, we demonstrate that passive immunization with a …

Cryptococcus neoformans Glucuronoxylomannan and Sterylglucoside Are Required for Host Protection in an Animal Vaccination Model

AC Colombo, A Rella, T Normile, LS Joffe, PM Tavares… - MBio, 2019 - Am Soc Microbiol
Cryptococcus neoformans is an encapsulated fungal pathogen that causes
meningoencephalitis. There are no prophylactic tools for cryptococcosis. Previously, our …

Evaluation of Cryptococcus neoformans galactoxylomannan–protein conjugate as vaccine candidate against murine cryptococcosis

SK Chow, A Casadevall - Vaccine, 2011 - Elsevier
Galactoxylomannan (GalXM) is a complex polysaccharide produced by the human
pathogenic fungus Cryptococcus neoformans that mediates profound immunological …

Semisynthetic Glycoconjugate Vaccine Candidates against Cryptococcus neoformans

CJ Crawford, L Liporagi-Lopes, C Coelho… - ACS Infectious …, 2024 - ACS Publications
Cryptococcus neoformans is a fungus classified by the World Health Organization as a
critically important pathogen, which poses a significant threat to immunocompromised …

Protection of mice against experimental cryptococcosis using glucan particle-based vaccines containing novel recombinant antigens

MM Hester, CK Lee, A Abraham, P Khoshkenar… - Vaccine, 2020 - Elsevier
Meningitis due to Cryptococcus neoformans is responsible for upwards of 180,000 deaths
worldwide annually, mostly in immunocompromised individuals. Currently there are no …

Protection against Experimental Cryptococcosis following Vaccination with Glucan Particles Containing Cryptococcus Alkaline Extracts

CA Specht, CK Lee, H Huang, DJ Tipper, ZT Shen… - MBio, 2015 - Am Soc Microbiol
ABSTRACT A vaccine capable of protecting at-risk persons against infections due to
Cryptococcus neoformans and Cryptococcus gattii could reduce the substantial global …

Role of Sterylglucosidase 1 (Sgl1) on the pathogenicity of Cryptococcus neoformans: potential applications for vaccine development

A Rella, V Mor, AM Farnoud, A Singh… - Frontiers in …, 2015 - frontiersin.org
Cryptococcosis caused by Cryptococcus neoformans and Cryptococcus gattii affects a large
population and is a cause of significant morbidity and mortality. Despite its public health …

Three Models of Vaccination Strategies Against Cryptococcosis in Immunocompromised Hosts Using Heat-Killed Cryptococcus neoformans Δsgl1

TG Normile, M Del Poeta - Frontiers in Immunology, 2022 - frontiersin.org
Vaccines are one of the greatest medical accomplishments to date, yet no fungal vaccines
are currently available in humans mainly because opportunistic mycoses generally occur …

Cryptococcus neoformans Δsgl1 Vaccination Requires Either CD4+ or CD8+ T Cells for Complete Host Protection

TG Normile, A Rella, M Del Poeta - Frontiers in Cellular and Infection …, 2021 - frontiersin.org
Cryptococcus neoformans is a fungal pathogen causing life-threatening
meningoencephalitis in susceptible individuals. Fungal vaccine development has been …